Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation
Clinical trial NCT03373461 · COMPLETED
Trial details
- NCT number
- NCT03373461
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-07
- Primary completion
- 2020-12-29
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.